Left Atrial Appendage Exclusion (LAAE) is recommended during heart surgery by The Society of Thoracic Surgeons, American College of Cardiology, and the American Heart Association
Afib patients face a high risk of HF death. Cardiac surgeons have the chance during valve or bypass surgery to halt HF progression, restore rhythm, & enhance post-op quality of life. Discover more: https://t.co/o4na6xEznD#Afib
We caught up with Drs. @CdeAsmundis and Mark La Meir at #HRS2024 after their presentation about IST and discussed how a new hybrid approach is being evaluated in the HEAL-IST Trial. Here’s what they had to say.
To learn more about HEAL-IST, visit: https://t.co/GctEkS7k6a.
That's a wrap at #HRS2024! We explored Hybrid AF™ Therapy with EPi-Sense System for LSPAF, gained insights from Dr. Oza’s hybrid ablation data, & learned about the HEAL-IST Trial's impact on IST patients from Drs. La Meir & @CdeAsmundis. Thanks all for shaping impactful futures!
Presented at #HRS2024, CEASE-AF Trial data demonstrated greater improvement in quality-of-life scores* among patients who underwent hybrid epicardial-endocardial ablation with LAAE with an AtriClip® device compared to endocardial catheter ablation alone.
See the data:… https://t.co/DA8wttJ3XL
During Hospital Week, we express our heartfelt gratitude to all the dedicated healthcare professionals who work tirelessly to provide exceptional care to patients every day.
Your unwavering commitment and compassion make a difference in the lives of countless individuals and families. Thank you for your resilience, courage, and unwavering dedication to healing and serving others.
#HospitalWeek
As we celebrate Women’s Health Week, we’re shining a light on IST, a condition that disproportionately affects young women. Symptoms such as a high resting heart rate, chest palpitations, lightheadedness, and anxiety can impact daily life. It's crucial for women to prioritize their health with regular check-ups and to speak up when symptoms arise.
At AtriCure, we're dedicated to advancing patient health. That's why we're proud to be running a new clinical trial, evaluating an innovative treatment option for symptomatic IST. Learn more about the trial: https://okt.to/uXp8DS
#WomensHealthWeek#ClinicalTrial#IST
We’re wishing all moms a Happy Mother's Day! Your love and sacrifices are immeasurable. Today, let's also acknowledge the importance of self-care. Remember, you can't pour from an empty cup. Take time to recharge, prioritize your health, and nurture your well-being. Here's to filling our cups with love and joy! #MothersDay#HappyMothersDay
We celebrate our employees at All Employee Meetings with the Heart of AtriCure Award. This award is one way we recognize employees who embody our values while demonstrating exceptional performance on behalf of each other, our patients and our partners. Congratulations to our recipients Paige Dwyer, Drew Mason, Deb Feldhaus, Amavi Kekeh and Gina Martin!
Today we’re also honoring Terrie Holahan, whose passing has been felt deeply across the AtriCure family. Terrie has been an integral part of AtriCure for over 20 years and her memory will live on with us.
#HeartofAtriCure#AEM#values#employeerecognition
Heart Failure is the leading cause of death in Afib patients.
However, cardiac surgeons have the golden opportunity during valve or bypass surgery to halt the progression of HF symptoms and restore sinus rhythm.
Treating Afib can improve the quality of life for patients after surgery; and help them return to a normal life expectancy curve.
To learn more about Afib treatment, visit https://okt.to/m6lFK2
We caught up with Drs. Carlo de Asmundis and Mark La Meir at #HRS2024 after their presentation about IST and discussed how a new hybrid approach is being evaluated in the HEAL-IST Trial. Here’s what they had to say.
To learn more about HEAL-IST, visit: HEAL-IST.com.
As #HRS2024 comes to a close, we're thrilled by the connections made. We delved into the potential of Hybrid AF™ Therapy with the EPi-Sense System for long-standing persistent Afib patients, absorbed insights from Dr. Oza's Hybrid ablation data, and learned about the HEAL-IST Trial's significance for IST patients through talks by doctors Mark La Meir and Carlo de Asmundis. Huge thanks to everyone involved for a weekend that's shaping impactful futures!
Presented at #HRS2024, CEASE-AF Trial data demonstrated greater improvement in quality-of-life scores* among patients who underwent hybrid epicardial-endocardial ablation with left atrial appendage exclusion with an AtriClip® device compared to endocardial catheter ablation alone.
To see more of the data, visit: https://okt.to/cMa0R8
*Derived from Short Form (SF-12) Physical and Mental Health Component Scores from baseline to 12-months.
social media channels to keep updated on the latest at AtriCure.
Blake's Pectus Excavatum Journey: 2 Months Post-Op
Duration: 2:31
Blake's Pectus Excavatum Journey: Surgery
Duration: 2:49
Blake's Pectus Excavatum Journey: 1 Week Pre-Op
Duration: 3:41
Blake's Pectus Excavatum Journey: 1 Month Pre-Op
Duration: 2:58